PMDA — authorised 29 June 2020
- Marketing authorisation holder: Sun Pharma Japan Ltd.
- Status: approved
🇯🇵 Sunpg 1622 in Japan
PMDA authorised Sunpg 1622 on 29 June 2020
Marketing authorisation
Sunpg 1622 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Sunpg 1622 approved in Japan?
Yes. PMDA authorised it on 29 June 2020.
Who is the marketing authorisation holder for Sunpg 1622 in Japan?
Sun Pharma Japan Ltd. holds the Japanese marketing authorisation.